A study restimulated CAR (+)-T cells through an endogenous cytomegalovirus (CMV)-specific T-cell receptor to enhance persistence and augment the anti-tumor activity of CD19-CAR-T cells [137]. This evidence concerns the gene CD19 and neoplasm.